Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 376

1.

Regulation of protective autophagy in anoikis-resistant glioma stem cells by SDCBP/MDA-9/Syntenin.

Talukdar S, Pradhan AK, Bhoopathi P, Shen XN, August LA, Windle JJ, Sarkar D, Furnari FB, Cavenee WK, Das SK, Emdad L, Fisher PB.

Autophagy. 2018 Aug 17:1-2. doi: 10.1080/15548627.2018.1502564. [Epub ahead of print]

PMID:
30118375
2.

Reply to Yoshida: Delineating critical roles of MDA-9 in protective autophagy-mediated anoikis resistance in human glioma stem cells.

Talukdar S, Das SK, Emdad L, Sarkar D, Cavenee WK, Fisher PB.

Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7654-E7655. doi: 10.1073/pnas.1811113115. Epub 2018 Aug 7. No abstract available.

PMID:
30087190
3.

Recombinant MDA-7/IL24 Suppresses Prostate Cancer Bone Metastasis through Downregulation of the Akt/Mcl-1 Pathway.

Pradhan AK, Bhoopathi P, Talukdar S, Shen XN, Emdad L, Das SK, Sarkar D, Fisher PB.

Mol Cancer Ther. 2018 Jun 22. doi: 10.1158/1535-7163.MCT-17-1002. [Epub ahead of print]

PMID:
29934341
4.

Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer.

Kumar BNP, Puvvada N, Rajput S, Sarkar S, Mahto MK, Yallapu MM, Pathak A, Emdad L, Das SK, Reis RL, Kundu SC, Fisher PB, Mandal M.

Mol Pharm. 2018 Jul 2;15(7):2698-2713. doi: 10.1021/acs.molpharmaceut.8b00218. Epub 2018 May 30.

PMID:
29787277
5.

MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells.

Talukdar S, Pradhan AK, Bhoopathi P, Shen XN, August LA, Windle JJ, Sarkar D, Furnari FB, Cavenee WK, Das SK, Emdad L, Fisher PB.

Proc Natl Acad Sci U S A. 2018 May 29;115(22):5768-5773. doi: 10.1073/pnas.1721650115. Epub 2018 May 14.

PMID:
29760085
6.

Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo.

Parekh A, Das S, Parida S, Das CK, Dutta D, Mallick SK, Wu PH, Kumar BNP, Bharti R, Dey G, Banerjee K, Rajput S, Bharadwaj D, Pal I, Dey KK, Rajesh Y, Jena BC, Biswas A, Banik P, Pradhan AK, Das SK, Das AK, Dhara S, Fisher PB, Wirtz D, Mills GB, Mandal M.

Oncogene. 2018 May 10. doi: 10.1038/s41388-018-0272-6. [Epub ahead of print]

PMID:
29743594
7.

Upregulation of neuronal astrocyte elevated gene-1 protects nigral dopaminergic neurons in vivo.

Leem E, Kim HJ, Choi M, Kim S, Oh YS, Lee KJ, Choe YS, Um JY, Shin WH, Jeong JY, Jin BK, Kim DW, McLean C, Fisher PB, Kholodilov N, Ahn KS, Lee JM, Jung UJ, Lee SG, Kim SR.

Cell Death Dis. 2018 May 1;9(5):449. doi: 10.1038/s41419-018-0491-3.

8.

The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.

Das SK, Pradhan AK, Bhoopathi P, Talukdar S, Shen XN, Sarkar D, Emdad L, Fisher PB.

Cancer Res. 2018 Jun 1;78(11):2852-2863. doi: 10.1158/0008-5472.CAN-17-2992. Epub 2018 Mar 23.

PMID:
29572229
9.

Prospects of Gene Therapy to Treat Melanoma.

Menezes ME, Talukdar S, Wechman SL, Das SK, Emdad L, Sarkar D, Fisher PB.

Adv Cancer Res. 2018;138:213-237. doi: 10.1016/bs.acr.2018.02.007.

PMID:
29551128
10.

Role of MDA-7/IL-24 a Multifunction Protein in Human Diseases.

Menezes ME, Bhoopathi P, Pradhan AK, Emdad L, Das SK, Guo C, Wang XY, Sarkar D, Fisher PB.

Adv Cancer Res. 2018;138:143-182. doi: 10.1016/bs.acr.2018.02.005. Epub 2018 Mar 2.

PMID:
29551126
11.

New Insights Into Beclin-1: Evolution and Pan-Malignancy Inhibitor Activity.

Wechman SL, Pradhan AK, DeSalle R, Das SK, Emdad L, Sarkar D, Fisher PB.

Adv Cancer Res. 2018;137:77-114. doi: 10.1016/bs.acr.2017.11.002. Epub 2017 Dec 27.

PMID:
29405978
12.

Bcl-2 Antiapoptotic Family Proteins and Chemoresistance in Cancer.

Maji S, Panda S, Samal SK, Shriwas O, Rath R, Pellecchia M, Emdad L, Das SK, Fisher PB, Dash R.

Adv Cancer Res. 2018;137:37-75. doi: 10.1016/bs.acr.2017.11.001. Epub 2017 Dec 6.

PMID:
29405977
13.

Cancer terminator viruses (CTV): A better solution for viral-based therapy of cancer.

Emdad L, Das SK, Wang XY, Sarkar D, Fisher PB.

J Cell Physiol. 2018 Aug;233(8):5684-5695. doi: 10.1002/jcp.26421. Epub 2018 Feb 27. Review.

PMID:
29278667
14.

The Enigma of miRNA Regulation in Cancer.

Pradhan AK, Emdad L, Das SK, Sarkar D, Fisher PB.

Adv Cancer Res. 2017;135:25-52. doi: 10.1016/bs.acr.2017.06.001. Epub 2017 Aug 7. Review.

PMID:
28882224
15.

Micellear Gold Nanoparticles as Delivery Vehicles for Dual Tyrosine Kinase Inhibitor ZD6474 for Metastatic Breast Cancer Treatment.

Sarkar S, Konar S, Prasad PN, Rajput S, Kumar BNP, Rao RR, Pathak A, Fisher PB, Mandal M.

Langmuir. 2017 Aug 8;33(31):7649-7659. doi: 10.1021/acs.langmuir.7b01072. Epub 2017 Jul 28.

PMID:
28701038
16.

IGFBP7 Deletion Promotes Hepatocellular Carcinoma.

Akiel M, Guo C, Li X, Rajasekaran D, Mendoza RG, Robertson CL, Jariwala N, Yuan F, Subler MA, Windle J, Garcia DK, Lai Z, Chen HH, Chen Y, Giashuddin S, Fisher PB, Wang XY, Sarkar D.

Cancer Res. 2017 Aug 1;77(15):4014-4025. doi: 10.1158/0008-5472.CAN-16-2885. Epub 2017 Jun 15.

17.

A novel role of astrocyte elevated gene-1 (AEG-1) in regulating nonalcoholic steatohepatitis (NASH).

Srivastava J, Robertson CL, Ebeid K, Dozmorov M, Rajasekaran D, Mendoza R, Siddiq A, Akiel MA, Jariwala N, Shen XN, Windle JJ, Subler MA, Mukhopadhyay ND, Giashuddin S, Ghosh S, Lai Z, Chen Y, Fisher PB, Salem AK, Sanyal AJ, Sarkar D.

Hepatology. 2017 Aug;66(2):466-480. doi: 10.1002/hep.29230. Epub 2017 Jun 30.

18.

Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma.

Jariwala N, Rajasekaran D, Mendoza RG, Shen XN, Siddiq A, Akiel MA, Robertson CL, Subler MA, Windle JJ, Fisher PB, Sanyal AJ, Sarkar D.

Cancer Res. 2017 Jun 15;77(12):3306-3316. doi: 10.1158/0008-5472.CAN-17-0298. Epub 2017 Apr 20.

19.

HIV induces expression of complement component C3 in astrocytes by NF-κB-dependent activation of interleukin-6 synthesis.

Nitkiewicz J, Borjabad A, Morgello S, Murray J, Chao W, Emdad L, Fisher PB, Potash MJ, Volsky DJ.

J Neuroinflammation. 2017 Jan 26;14(1):23. doi: 10.1186/s12974-017-0794-9.

20.

Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy.

Bharti R, Dey G, Banerjee I, Dey KK, Parida S, Kumar BN, Das CK, Pal I, Mukherjee M, Misra M, Pradhan AK, Emdad L, Das SK, Fisher PB, Mandal M.

Cancer Lett. 2017 Mar 1;388:292-302. doi: 10.1016/j.canlet.2016.12.021. Epub 2016 Dec 24.

PMID:
28025102

Supplemental Content

Loading ...
Support Center